Quick Takeaways
- Samuel D. Tweardy filed SCHEDULE 13G/A for TVARDI THERAPEUTICS, INC. Common Stock, par value $0.001 per share (CARA).
- Disclosed ownership: 3.4%.
- Date of event: 07 Jul 2025.
Samuel D. Tweardy - 07 Jul 2025 SCHEDULE 13G/A Report for TVARDI THERAPEUTICS, INC. Common Stock, par value $0.001 per share (CARA)
- Filing Manager
- Samuel D. Tweardy
- Reporting Manager
- Samuel D. Tweardy
- Symbol
- CARA
- Shares outstanding
- 9,284,059 shares
- Disclosed Ownership
- 315,658 shares
- Ownership
- 3.4%
- Form type
- SCHEDULE 13G/A
- Filing time
- 05 Aug 2025, 20:04:44 UTC
- Date of event
- 07 Jul 2025
- Previous filing
- 02 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Samuel D. Tweardy disclosed 3.4% ownership in TVARDI THERAPEUTICS, INC. Common Stock, par value $0.001 per share (CARA) on 07 Jul 2025."
What Changed
- Previous schedule filing date: 02 May 2025.
- Current filing was accepted on 05 Aug 2025, 20:04.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Samuel D. Tweardy | 3.4% | 315,658 | 315,658 | 0 | /s/ Samuel D. Tweardy | Samuel D. Tweardy |